USPTO serial 87070364
CONQUERING ALZHEIMER'S THROUGH DRUG DISCOVERY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 25, 2017
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CONQUERING ALZHEIMER'S THROUGH DRUG DISCOVERY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Alzheimer's Drug Discovery Foundation
New York, NY
Other trademarks owned by Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation
New York, NY
Other trademarks owned by Alzheimer's Drug Discovery Foundation
Alzheimer's Drug Discovery Foundation
New York, NY
Other trademarks owned by Alzheimer's Drug Discovery Foundation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Greg Lam
GREG LAM COPILEVITZ & CANTER, LLC310 W. 20TH STREET, SUITE 300KANSAS CITY, MO 64108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Charitable fundraising services and accepting and administering monetary charitable contributions to find a means to prevent, cure, or otherwise treat Alzheimer's disease; charitable services, namely, providing fundraising to support medical research funding | SECTION 8 - CANCELLED | Sep 21, 2011 |
| 044 | Charitable services, namely, providing educational information to physicians on suggested therapies and related issues to prevent, treat, and cure Alzheimer's and maintain cognitive vitality | SECTION 8 - CANCELLED | Sep 21, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Alzheimer's Drug Discovery Foundation
- Other trademarks owned by Alzheimer's Drug Discovery Foundation
- Other trademarks owned by Alzheimer's Drug Discovery Foundation
- Other trademarks in Class 036
- Other trademarks in Class 044
- Similar marks named CONQUERING ALZHEIMER'S THROUGH DRUG DISCOVERY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 25, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 25, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 17, 2017 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 16, 2016 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 1, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 1, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 12, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 20, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 20, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2016 | NWAP | NEW APPLICATION ENTERED | — |